Anna E Hosman
Overview
Explore the profile of Anna E Hosman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
157
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bofarid S, Hosman A, Mager J, Snijder R, Post M
Int J Mol Sci
. 2021 Apr;
22(7).
PMID: 33801690
In this review, we discuss the role of transforming growth factor-beta (TGF-β) in the development of pulmonary vascular disease (PVD), both pulmonary arteriovenous malformations (AVM) and pulmonary hypertension (PH), in...
2.
de Gussem E, Kroon S, Hosman A, Kelder J, Post M, Snijder R, et al.
J Clin Med
. 2020 Nov;
9(11).
PMID: 33172103
Hereditary hemorrhagic telangiectasia (HHT), an autosomal dominant disease, is characterized by telangiectases and arteriovenous malformations (AVMs). Untreated AVMs, especially in the lungs-pulmonary AVMs (PAVMs)-can result in morbidity with a decreased...
3.
Kroon S, van Thor M, Vorselaars V, Hosman A, Swaans M, Snijder R, et al.
Eur Heart J Cardiovasc Imaging
. 2020 Jul;
22(10):1190-1196.
PMID: 32667638
Aims: Transthoracic contrast echocardiography (TTCE) is the recommended screening tool to detect pulmonary right-to-left shunt (RLS) caused by pulmonary arteriovenous malformations (PAVMs). We assessed a novel method to quantify the...
4.
Kroon S, Vorselaars V, Hosman A, Post M, Snijder R, Mager J
Vasc Med
. 2020 Apr;
25(4):341-347.
PMID: 32303156
Abnormal vasculature is a key feature of hereditary hemorrhagic telangiectasia (HHT) and can also present in the nail fold capillary beds. However, the exact prevalence and the clinical diagnostic value...
5.
Thalgott J, Dos-Santos-Luis D, Hosman A, Martin S, Lamande N, Bracquart D, et al.
Circulation
. 2018 Dec;
138(23):2698-2712.
PMID: 30571259
Background: Hereditary Hemorrhagic Telangiectasia type 2 (HHT2) is an inherited genetic disorder characterized by vascular malformations and hemorrhage. HHT2 results from ACVRL1 haploinsufficiency, the remaining wild-type allele being unable to...
6.
Vorselaars V, Hosman A, Westermann C, Snijder R, Mager J, Goumans M, et al.
Int J Mol Sci
. 2018 Oct;
19(10).
PMID: 30336550
Hereditary haemorrhagic telangiectasia (HHT) is an autosomal dominant inherited disease characterised by multisystemic vascular dysplasia. Heritable pulmonary arterial hypertension (HPAH) is a rare but severe complication of HHT. Both diseases...
7.
Andrejecsk J, Hosman A, Botella L, Shovlin C, Arthur H, Dupuis-Girod S, et al.
Angiogenesis
. 2017 Nov;
21(1):169-181.
PMID: 29147802
Hereditary hemorrhagic telangiectasia is an autosomal dominant trait affecting approximately 1 in 5000 people. A pathogenic DNA sequence variant in the ENG, ACVRL1 or SMAD4 genes, can be found in...
8.
Hosman A, de Gussem E, Balemans W, Gauthier A, Westermann C, Snijder R, et al.
Pediatr Pulmonol
. 2017 Apr;
52(9):1206-1211.
PMID: 28407366
Background: Hereditary Hemorrhagic Telangiectasia (HHT) is an autosomal dominant disease with multi-systemic vascular dysplasia. Early diagnosis through screening is important to prevent serious complications. How best to screen children of...
9.
Hosman A, Devlin H, Silva B, Shovlin C
Orphanet J Rare Dis
. 2013 Dec;
8:195.
PMID: 24354965
Background: Hereditary haemorrhagic telangiectasia (HHT) is inherited as an autosomal dominant trait, affects ~1 in 5,000, and causes multi-systemic vascular lesions and life-limiting complications. Life expectancy is surprisingly good, particularly...
10.
Devlin H, Hosman A, Shovlin C
N Engl J Med
. 2013 Mar;
368(9):876-8.
PMID: 23445111
No abstract available.